Revenue | ₹27.80Cr |
Net Profits | ₹0.46Cr |
Net Profit Margins | 1.65% |
Sotac Pharmaceuticals Ltd’s revenue jumped 4% since last year same period to ₹27.80Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated 9.02% jump in its revenue since last 3-months.
Sotac Pharmaceuticals Ltd’s net profit fell -29.23% since last year same period to ₹0.46Cr in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -68.28% fall in its net profits since last 3-months.
Sotac Pharmaceuticals Ltd’s net profit margin fell -31.95% since last year same period to 1.65% in the Q2 2024-2025. On a quarterly growth basis, Sotac Pharmaceuticals Ltd has generated -70.9% fall in its net profit margins since last 3-months.
The revenue for Sotac Pharmaceuticals Ltd in the Q2 results 2024 was ₹27.80Cr.
The net profit for Sotac Pharmaceuticals Ltd in the Q2 results 2024 was ₹0.46Cr.
The net profit margin for Sotac Pharmaceuticals Ltd in the Q2 results 2024 was 1.65%.
The revenue for Sotac Pharmaceuticals Ltd in the Q2 results 2023 was ₹26.73Cr.
The net profit for Sotac Pharmaceuticals Ltd in the Q2 results 2023 was ₹0.65Cr.
The net profit margin for Sotac Pharmaceuticals Ltd in the Q2 results 2023 was 2.43%.